首页> 外国专利> POLYNUCLEOTIDES AND POLYPEPTIDES LINKED TO BLOOD PRESSURE REGULATION AND/OR FATIGUE

POLYNUCLEOTIDES AND POLYPEPTIDES LINKED TO BLOOD PRESSURE REGULATION AND/OR FATIGUE

机译:与血液压力调节和/或疲劳有关的多核苷酸和多肽

摘要

The present invention relates to genetic mutations in the corticosteroid binding globulin (CBG) gene or to aberrant CBG expression products, which segregate with at least one condition selected from hypotension or a fatigue related disorder. The invention also relates to methods for detecting such mutations or expression products, as a diagnostic for said at least one condition, either before or after the onset of clinical symptoms. More specifically, the present invention provides a method for detecting the presence or diagnosing the risk of at least one condition selected from hypotension or a fatigue related disorder by determining the presence of at least one mutation in the sequence of a CGB gene or of an aberrant CBG expression product, which correlates with the presence or risk of said at least one condition. The present invention also encompasses a method of detecting genetic mutations or aberrant expression products, which cause a predisposition to at least one condition selected from hypotension or a fatigue related disorder, by first determining the sequence of a CGB gene or expression product thereof from subjects known to have said at least one condition and comparing the sequence to that of wild-type CBG genes or wild-type CBG expression products to thereby identify said mutations or aberrant expression products. The invention is also concerned with isolated nucleic acid sequences, which correspond, or which are complementary, to at least a portion of a CBG gene or transcript thereof, wherein the sequences contain a mutation or aberration, which correlates with the presence or risk of said at least one condition. The invention further relates to isolated mutant or aberrant CBG polypeptides encoded by mutant CBG genes or by aberrant transcripts thereof. The invention also relates to use of functional CBG polynucleotides, functional CBG polypeptides and glucocorticoids in methods for treating or preventing one or more of said conditions.
机译:本发明涉及皮质类固醇结合球蛋白(CBG)基因中的遗传突变或异常的CBG表达产物,其与选自低血压或疲劳相关疾病的至少一种病症分离。本发明还涉及在临床症状发作之前或之后,检测此类突变或表达产物的方法,作为对所述至少一种状况的诊断。更具体地说,本发明提供了一种通过确定CGB基因或异常序列中至少一个突变的存在来检测至少一种选自低血压或与疲劳有关的疾病的存在或诊断风险的方法。 CBG表达产物,其与所述至少一种病症的存在或风险相关。本发明还包括通过首先确定来自已知受试者的CGB基因或其表达产物的序列来检测遗传突变或异常表达产物的方法,所述遗传突变或异常表达产物导致易患至少一种选自低血压或与疲劳相关的疾病的病症。具有所述至少一种条件,并将所述序列与野生型CBG基因或野生型CBG表达产物的序列进行比较,从而鉴定所述突变或异常表达产物。本发明还涉及与CBG基因或其转录物的至少一部分相对应或互补的分离的核酸序列,其中所述序列包含突变或畸变,其与所述CBG基因或其转录物的存在或风险相关。至少一种情况。本发明进一步涉及由突变CBG基因或其异常转录本编码的分离的突变或异常CBG多肽。本发明还涉及功能性CBG多核苷酸,功能性CBG多肽和糖皮质激素在治疗或预防一种或多种所述病症的方法中的用途。

著录项

  • 公开/公告号WO0198487A8

    专利类型

  • 公开/公告日2002-04-04

    原文格式PDF

  • 申请/专利权人 THE UNIVERSITY OF QUEENSLAND;TORPY DAVID JAMES;

    申请/专利号WO2001AU00736

  • 发明设计人 TORPY DAVID JAMES;

    申请日2001-06-21

  • 分类号C12N15/12;A61K38/17;C07K14/47;

  • 国家 WO

  • 入库时间 2022-08-22 00:38:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号